Login / Signup

Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.

Alfred D NelsonChristopher J BlackLesley A HoughtonNahyr Sofía Lugo-FagundoBrian E LacyAlexander Charles Ford
Published in: Alimentary pharmacology & therapeutics (2021)
We found all licensed drugs for IBS-C to be superior to placebo for abdominal bloating. Linaclotide appeared to be the most efficacious at relieving abdominal bloating. Further research is needed to assess long-term efficacy of these agents and to better understand the precise mechanism of improving bloating.
Keyphrases
  • irritable bowel syndrome
  • randomized controlled trial